Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Rating of “Moderate Buy” from Analysts

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has earned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $27.3333.

A number of analysts have weighed in on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Kestra Medical Technologies in a research report on Wednesday, October 8th. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, September 28th.

Institutional Trading of Kestra Medical Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in KMTS. Quarry LP purchased a new position in Kestra Medical Technologies during the first quarter worth about $33,000. China Universal Asset Management Co. Ltd. acquired a new position in Kestra Medical Technologies during the 3rd quarter worth approximately $48,000. Police & Firemen s Retirement System of New Jersey purchased a new position in shares of Kestra Medical Technologies during the 2nd quarter worth approximately $54,000. BNP Paribas Financial Markets lifted its holdings in shares of Kestra Medical Technologies by 148.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company’s stock valued at $65,000 after buying an additional 1,638 shares during the period. Finally, Brown Brothers Harriman & Co. boosted its stake in shares of Kestra Medical Technologies by 26.8% in the third quarter. Brown Brothers Harriman & Co. now owns 3,104 shares of the company’s stock valued at $74,000 after buying an additional 656 shares in the last quarter.

Kestra Medical Technologies Trading Up 0.4%

Shares of Kestra Medical Technologies stock opened at $25.02 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 6.84 and a current ratio of 6.84. The company has a market capitalization of $1.29 billion and a P/E ratio of -9.81. Kestra Medical Technologies has a 1 year low of $13.25 and a 1 year high of $30.00. The company’s fifty day moving average is $24.52 and its two-hundred day moving average is $20.46.

Kestra Medical Technologies (NASDAQ:KMTS) last announced its earnings results on Thursday, September 11th. The company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.66) by $0.16. The business had revenue of $19.37 million for the quarter, compared to analyst estimates of $17.68 million. Kestra Medical Technologies has set its FY 2026 guidance at EPS.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.